Member Exclusive News

The week in industry: Breakthrough approval for cystic fibrosis

This week: Takeda (Tokyo, Japan) acquire rights to license Celiac disease therapy, new company launched for novel immune system-modulating drugs and a dementia drug discovery collaboration is announced.

Go to the profile of RxNet
Oct 24, 2019

Please sign in or register for FREE

No comments yet.